Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taniwaki, H.
Right arrow Articles by Nishizawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniwaki, H.
Right arrow Articles by Nishizawa, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:132-137, 2003
© 2003 by the American Diabetes Association, Inc.


Emerging Treatments and Technologies
Original Article

Intrarenal Hemodynamic Changes After Captopril Test in Patients With Type 2 Diabetes

A duplex Doppler sonography study

Hiromichi Taniwaki, MD1, Eiji Ishimura, MD2, Takahiko Kawagishi, MD1, Naoki Matsumoto, MD1, Masayuki Hosoi, MD1, Masanori Emoto, MD1, Tetsuo Shoji, MD1, Shigeichi Shoji, MD3, Tatsuya Nakatani, MD4, Masaaki Inaba, MD1 and Yoshiki Nishizawa, MD1

1 Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan
2 Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan
3 Department of Internal Medicine, Inoue Hospital, Inoue, Japan
4 Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan

OBJECTIVE—ACE inhibitors are known to be effective in preventing the progression of diabetic nephropathy. Activation of the renin-angiotensin system (RAS) is reported to contribute to intrarenal hemodynamic abnormality in diabetic patients. We examined whether RAS blockade by captopril induces intrarenal hemodynamic changes in normotensive patients with type 2 diabetes.

RESEARCH DESIGN AND METHODS—The patients ranged in age from 40 to 65 years (20 men and 20 women). A total of 15 age- and sex-matched healthy individuals served as control subjects. Resistive index (RI) of interlobar arteries was examined by duplex Doppler sonography before and after the oral captopril (25 mg) test.

RESULTS—At baseline, no significant differences in RI values or plasma renin activity (PRA) were seen between the patients and healthy subjects. In healthy subjects, the RI values after the captopril test were significantly higher than baseline values (P < 0.01). However, in patients with type 2 diabetes, both with normoalbuminuria and microalbuminuria, RI values after the test were significantly lower than baseline values (P < 0.001). There were significant negative correlations between {Delta}RI value and HbA1c (r = -0.458, P < 0.005) and between {Delta}RI value and baseline PRA in diabetic patients (r = -0.339, P < 0.05). Multiple regression analysis showed that HbA1c and baseline PRA significantly and independently affected the magnitude of decrease in RI values after captopril administration in diabetic patients (R2 = 0.391, P < 0.0001).

CONCLUSIONS—These results indicate that the intrarenal RAS may be activated in diabetic patients, that such activation may be affected by poor glycemic control, and that blockade of RAS activation by ACE inhibitor reduces intrarenal vascular resistance in diabetic patients. The results emphasize the beneficial effects of ACE inhibition in improving intrarenal hemodynamics in diabetic patients.

Abbreviations: EDV, end-diastolic flow velocity • PA, plasma aldosterone • PRA, plasma renin activity • PSV, peak systolic flow velocity • RAS, renin-angiotensin system • RI, resistive index • UAE, urinary albumin excretion


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
S. Giunti, D. Barit, and M. E. Cooper
Mechanisms of Diabetic Nephropathy: Role of Hypertension
Hypertension, October 1, 2006; 48(4): 519 - 526.
[Full Text] [PDF]


Home page
Diabetes CareHome page
R. J. MacIsaac, S. Panagiotopoulos, K. J. McNeil, T. J. Smith, C. Tsalamandris, H. Hao, P. G. Matthews, M. C. Thomas, D. A. Power, and G. Jerums
Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease?
Diabetes Care, July 1, 2006; 29(7): 1560 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. C. Thomas, C. Tikellis, W. M. Burns, K. Bialkowski, Z. Cao, M. T. Coughlan, K. Jandeleit-Dahm, M. E. Cooper, and J. M. Forbes
Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2976 - 2984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.